Dr. Andrea Rubbert-Roth, MD
Claim this profileKantonsspital St. Gallen
Studies Systemic Scleroderma
Studies Scleroderma
1 reported clinical trial
1 drug studied
More about Andrea Rubbert-Roth, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Andrea Rubbert-Roth, MD has experience with
- HZN-825
Breakdown of trials Andrea Rubbert-Roth, MD has run
Systemic Scleroderma
Scleroderma
Sclerosis
Systemic Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea Rubbert-Roth, MD specialize in?
Andrea Rubbert-Roth, MD focuses on Systemic Scleroderma and Scleroderma. In particular, much of their work with Systemic Scleroderma has involved treating patients, or patients who are undergoing treatment.
Is Andrea Rubbert-Roth, MD currently recruiting for clinical trials?
No, Andrea Rubbert-Roth, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Andrea Rubbert-Roth, MD has studied deeply?
Yes, Andrea Rubbert-Roth, MD has studied treatments such as HZN-825.
What is the best way to schedule an appointment with Andrea Rubbert-Roth, MD?
Apply for one of the trials that Andrea Rubbert-Roth, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.